About Technology Issues FAQ

Links

Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.